Traws Pharma Files 2024 Annual Report
Ticker: TRAW · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceutical, annual-report
TL;DR
Traws Pharma (fka Onconova) dropped its 2024 10-K. Check financials.
AI Summary
Traws Pharma, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as Onconova Therapeutics, Inc., is based in Newtown, PA. The filing details financial information and business operations for the period.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Traws Pharma's financial health and strategic direction for the past fiscal year.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Traws Pharma is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 3650731 — Total Assets (Reported for the fiscal year ending 12-31-2024)
- 0.04 — Current Ratio (Indicates short-term liquidity for the fiscal year ending 12-31-2024)
Key Players & Entities
- Traws Pharma, Inc. (company) — Filer of the 10-K
- Onconova Therapeutics, Inc. (company) — Former name of Traws Pharma, Inc.
- 2024-12-31 (date) — Fiscal year end date
- 2025-03-31 (date) — Filing date
- Newtown, PA (location) — Business and mailing address
FAQ
What were Traws Pharma's total revenues for the fiscal year ended December 31, 2024?
The provided text does not explicitly state the total revenues for the fiscal year ended December 31, 2024. It focuses on other financial data points like assets and ratios.
What is the company's primary business activity?
Traws Pharma, Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
When did the company change its name from Onconova Therapeutics, Inc.?
The company changed its name from Onconova Therapeutics, Inc. on May 26, 2009.
What is the company's SEC file number?
The SEC file number for Traws Pharma, Inc. is 001-36020.
What are some of the inputs used in the fair value measurement of Series Warrants?
Inputs mentioned for the fair value measurement of Series Warrants include risk-free interest rate, price volatility, and expected term, categorized under FairValueInputsLevel3Member.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Traws Pharma, Inc. (TRAW).